Nasal and paranasal sinus mucosal melanoma: Long-term survival outcomes and prognostic factors

  • Nicholas B. Abt
  • , Lauren E. Miller
  • , Tara E. Mokhtari
  • , Derrick T. Lin
  • , Jeremy D. Richmon
  • , Daniel G. Deschler
  • , Mark A. Varvares
  • , Sidharth V. Puram

Research output: Contribution to journalReview articlepeer-review

Abstract

Objective: To determine prognostic factors and survival patterns for different treatment modalities for nasal cavity (NC) and paranasal sinus (PS) mucosal melanoma (MM). Methods: Patients from 1973 to 2013 were analyzed using the Surveillance, Epidemiology, and End Results (SEER) database. Kaplan-Meier method and multivariable cox proportional hazard modeling were used for survival analyses. Results: Of 928 cases of mucosal melanoma (NC = 632, PS = 302), increasing age (Hazard Ratio [HR]:1.05/year, p < 0.001), T4 tumors (HR: 1.81, p = 0.02), N1 status (HR: 6.61, p < 0.001), and PS disease (HR: 1.50, p < 0.001) were associated with worse survival. Median survival length was lower for PS versus NC (16 versus 26 months, p < 0.001). Surgery and surgery + radiation therapy (RT) improved survival over non-treatment or RT alone (p < 0.001). Adding RT to surgery did not yield a survival difference compared with surgery alone (p = 0.43). Five-year survival rates for surgery and surgery + RT were similar, at 27.7% and 25.1% (p = 0.43). Conclusion: Surgery increased survival significantly over RT alone. RT following surgical resection did not improve survival.

Original languageEnglish
Article number103070
JournalAmerican Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume42
Issue number6
DOIs
StatePublished - Nov 1 2021

Keywords

  • Cancer
  • Melanoma
  • Mucosal
  • Nasal cavity
  • Neoplasm
  • Paranasal sinus
  • Survival
  • Tumor

Fingerprint

Dive into the research topics of 'Nasal and paranasal sinus mucosal melanoma: Long-term survival outcomes and prognostic factors'. Together they form a unique fingerprint.

Cite this